{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:35Z","timestamp":1792791515272,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008556","name":"Paul Mackall and Evanina Bell Mackall Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018132","name":"Pennsylvania Lions Sight Conservation & Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ymthe.2025.06.035","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:29:06Z","timestamp":1751426946000},"page":"4784-4798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I\/II trial"],"prefix":"10.1016","volume":"33","author":[{"given":"Tomas S.","family":"Aleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Uyhazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariejel L.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C.","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Swider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sumaroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine H.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene J.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey M.","family":"Parchinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Billek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makayla","family":"Fradin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew H.","family":"Scoles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra V.","family":"Garafalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwath","family":"Jayagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Yerxa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert M.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur V.","family":"Cideciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.06.035_bib1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib2","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib3","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib4","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.035_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/hum.2009.086","article-title":"Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year","volume":"20","author":"Cideciyan","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib7","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.035_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.06.035_bib9","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.06.035_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105274","article-title":"Night vision restored in days after decades of congenital blindness","volume":"25","author":"Jacobson","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.06.035_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102409","article-title":"Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations","volume":"24","author":"Jacobson","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.06.035_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(24)01447-8","article-title":"Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1\/2, multicentre, open-label, unilateral dose escalation study","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.06.035_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41591-021-01297-7","article-title":"Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report","volume":"27","author":"Cideciyan","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100133","article-title":"Restoration of Cone Sensitivity to Individuals with Congenital Photoreceptor Blindness within the Phase 1\/2 Sepofarsen Trial","volume":"2","author":"Cideciyan","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib16","article-title":"Durable vision improvement after a single intravitreal treatment with antisense oligonucleotide in CEP290-LCA: Replication in two eyes","volume":"32","author":"Cideciyan","year":"2023","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.ymthe.2025.06.035_bib17","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene Editing for CEP290-Associated Retinal Degeneration","volume":"390","author":"Pierce","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gde.2019.05.004","article-title":"The photoreceptor cilium and its diseases","volume":"56","author":"Bachmann-Gagescu","year":"2004","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ymthe.2025.06.035_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ng2066","article-title":"Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis","volume":"39","author":"den Hollander","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.06.035_bib20","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI45627","article-title":"Disruption of intraflagellar protein transport in photoreceptor cilia causes Leber congenital amaurosis in humans and mice","volume":"121","author":"Boldt","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.06.035_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","article-title":"Leber congenital amaurosis: genes, proteins and disease mechanisms","volume":"27","author":"den Hollander","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajhg.2009.09.002","article-title":"OFD1 is mutated in X-linked Joubert syndrome and interacts with LCA5-encoded lebercilin","volume":"85","author":"Coene","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.06.035_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001649","article-title":"The connecting cilium inner scaffold provides a structural foundation that protects against retinal degeneration","volume":"20","author":"Mercey","year":"2022","journal-title":"Plos Biol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169162","article-title":"Gene augmentation of LCA5-associated Leber congenital amaurosis ameliorates bulge region defects of the photoreceptor ciliary axoneme","volume":"8","author":"Faber","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.06.035_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ymthe.2018.03.015","article-title":"Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital Blindness","volume":"26","author":"Song","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib26","article-title":"Preparation for a Gene Therapy Trial for LCA5-Associated Retinal Degenerations: Treatment Potential in Patients and Dose-ranging Studies in Non-human Primates","volume":"63","author":"Margaritis","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib27","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1073\/pnas.0500646102","article-title":"Identifying photoreceptors in blind eyes due to RPE65 mutations:Prerequisite for human gene therapy success","volume":"102","author":"Jacobson","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","article-title":"Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy","volume":"29","author":"Maguire","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100827","article-title":"Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives","volume":"77","author":"Garafalo","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/humu.20565","article-title":"Centrosomal-ciliary gene CEP290\/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis","volume":"28","author":"Cideciyan","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2025.06.035_bib31","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/hmg\/ddr022","article-title":"Cone photoreceptors are the main targets for gene therapy of NPHP5 (IQCB1) or NPHP6 (CEP290) blindness: generation of an all-cone Nphp6 hypomorph mouse that mimics the human retinal ciliopathy","volume":"20","author":"Cideciyan","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.06.035_bib32","first-page":"3785","article-title":"Safety and Efficacy of EDIT-101 for Treatment of CEP290-associated Retinal Degeneration","volume":"64","author":"Pierce","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2017.02.003","article-title":"Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations","volume":"177","author":"Jacobson","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1086\/302719","article-title":"A novel locus for Leber congenital amaurosis maps to chromosome 6q","volume":"66","author":"Dharmaraj","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.06.035_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bjo.87.4.473","article-title":"Progression of phenotype in Leber's congenital amaurosis with a mutation at the LCA5 locus","volume":"87","author":"Mohamed","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/humu.9513","article-title":"Mutations in LCA5 are an uncommon cause of Leber congenital amaurosis (LCA) type II","volume":"28","author":"Gerber","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2025.06.035_bib37","first-page":"481","article-title":"Identification of a novel splice-site mutation in the Lebercilin (LCA5) gene causing Leber congenital amaurosis","volume":"14","author":"Ramprasad","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2025.06.035_bib38","first-page":"1098","article-title":"Leber congenital amaurosis caused by Lebercilin (LCA5) mutation: retained photoreceptors adjacent to retinal disorganization","volume":"15","author":"Jacobson","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2025.06.035_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13816810802592567","article-title":"LCA5, a rare genetic cause of leber congenital amaurosis in Koreans","volume":"30","author":"Seong","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2025.06.035_bib40","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1167\/iovs.08-2696","article-title":"Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations","volume":"50","author":"Jacobson","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archophthalmol.2010.309","article-title":"Genotype-phenotype correlation for leber congenital amaurosis in Northern Pakistan","volume":"128","author":"McKibbin","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib42","first-page":"1940","article-title":"Identification of a novel LCA5 mutation in a Pakistani family with Leber congenital amaurosis and cataracts","volume":"17","author":"Ahmad","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2025.06.035_bib43","article-title":"Detection of Variants in 15 Genes in 87 Unrelated Chinese Patients with Leber Congenital Amaurosis","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.035_bib44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/humu.22398","article-title":"Screening of a Large Cohort of Leber Congenital Amaurosis and Retinitis Pigmentosa Patients Identifies Novel LCA5 Mutations and New Genotype-Phenotype Correlations","volume":"34","author":"Mackay","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2025.06.035_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1101\/gr.144105.112","article-title":"Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes","volume":"23","author":"Abu-Safieh","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ophtha.2013.08.028","article-title":"Involvement of LCA5 in Leber congenital amaurosis and retinitis pigmentosa in the Spanish population","volume":"121","author":"Corton","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.06.035_bib47","article-title":"Next-generation Sequencing Extends the Phenotypic Spectrum for LCA5 Mutations: Novel LCA5 Mutations in Cone Dystrophy","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.06.035_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.61.5.30","article-title":"Treatment Potential for LCA5-Associated Leber Congenital Amaurosis","volume":"61","author":"Uyhazi","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib49","article-title":"Relative preservation of the extramacular retina in LCA5-associated Leber congenital amaurosis","volume":"25","author":"O'Connor","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.ymthe.2025.06.035_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116151","article-title":"Four Unique Genetic Variants in Three Genes Account for 62.7% of Early-Onset Severe Retinal Dystrophy in Chile: Diagnostic and Therapeutic Consequences","volume":"25","author":"Moya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib51","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.4.3","article-title":"Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9\/2020","volume":"10","author":"Chan","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101000","article-title":"Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease","volume":"87","author":"Roman","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.65.14.30","article-title":"Retinal Degeneration Associated With Biallelic RDH12 Variants: Longitudinal Evaluation of Retinal Structure and Visual Function in Pediatric Patients","volume":"65","author":"Aleman","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib54","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1167\/iovs.03-1230","article-title":"Impairment of the transient pupillary light reflex in Rpe65(-\/-) mice and humans with leber congenital amaurosis","volume":"45","author":"Aleman","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-vision-032321-091738","article-title":"Measures of Function and Structure to Determine Phenotypic Features, Natural History, and Treatment Outcomes in Inherited Retinal Diseases","volume":"7","author":"Cideciyan","year":"2021","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/OPTH.S292527","article-title":"A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene Therapy","volume":"15","author":"Aleman","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/tvst.12.1.28","article-title":"Optimization and validation of a virtual reality orientation and mobility test for inherited retinal degenerations","volume":"12","author":"Bennett","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib58","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25)","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib59","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41401-020-0486-3","article-title":"Targeting the photoreceptor cilium for the treatment of retinal diseases","volume":"41","author":"Ran","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ymthe.2025.06.035_bib60","series-title":"Probing the Sub-cellular Mechanisms of LCA5-Leber Congenital Amaurosis and Associated Gene Therapy with Expansion Microscopy","author":"Faber","year":"2023"},{"key":"10.1016\/j.ymthe.2025.06.035_bib61","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1167\/iovs.17-21560","article-title":"Outcome Measures for Clinical Trials of Leber Congenital Amaurosis Caused by the Intronic Mutation in the CEP290 Gene","volume":"58","author":"Jacobson","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1167\/iovs.16-20413","article-title":"Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene","volume":"58","author":"Aguirre","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib63","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.omtm.2023.05.012","article-title":"CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids","volume":"29","author":"Afanasyeva","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.035_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(25)00232-6","article-title":"Gene therapy for young children with congenital blindness","volume":"405","author":"Cideciyan","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.06.035_bib65","article-title":"Relative preservation of the extramacular retina in LCA5-LCA","volume":"25","author":"O'Connor","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.ymthe.2025.06.035_bib66","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/IAE.0000000000000144","article-title":"Psychophysical measurement of rod and cone thresholds in stargardt disease with full-field stimuli","volume":"34","author":"Collison","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.ymthe.2025.06.035_bib67","article-title":"Blue Cone Monochromacy: Visual Function and Efficacy Outcome Measures for Clinical Trials","volume":"10","author":"Luo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.035_bib68","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1167\/iovs.11-7701","article-title":"Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model","volume":"52","author":"Aleman","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib69","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.bbadis.2019.07.009","article-title":"Knocking out lca5 in zebrafish causes cone-rod dystrophy due to impaired outer segment protein trafficking","volume":"1865","author":"Qu","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2025.06.035_bib70","article-title":"AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I\/II Gene Therapy Trial","volume":"58","author":"Aleman","year":"2017","journal-title":"ARVO"},{"key":"10.1016\/j.ymthe.2025.06.035_bib71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","article-title":"Gene-based therapies for neurodegenerative diseases","volume":"24","author":"Sun","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib73","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/ijms23031851","article-title":"A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib74","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","article-title":"AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial","volume":"403","author":"Lv","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.06.035_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000526317","article-title":"Gene Therapy for Inherited Retinal Disease: Long-Term Durability of Effect","volume":"66","author":"Leroy","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib76","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jgm.2768","article-title":"Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models","volume":"16","author":"Black","year":"2014","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/hum.2016.111","article-title":"Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina","volume":"28","author":"Ramachandran","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib80","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/jvi.70.1.520-532.1996","article-title":"Transduction with Recombinant Adeno-Associated Virus for Gene Therapy is Limited by Leading-Strand Synthesis","volume":"70","author":"Fisher","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib81","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2021.05.011","article-title":"Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina","volume":"22","author":"Chandler","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.035_bib82","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib83","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1167\/iovs.17-22494","article-title":"Humoral Immune Response After Intravitreal But Not After Subretinal AAV8 in Primates and Patients","volume":"59","author":"Reichel","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib84","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1167\/iovs.17-22473","article-title":"Superior Retinal Gene Transfer and Biodistribution Profile of Subretinal Versus Intravitreal Delivery of AAV8 in Nonhuman Primates","volume":"58","author":"Seitz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.14.1.29","article-title":"Ocular Safety and Toxicology of Subretinal Gene Therapy With rAAV","volume":"14","author":"Seitz","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib86","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1089\/hum.2017.155","article-title":"Gene Supplementation Rescues Rod Function and Preserves Photoreceptor and Retinal Morphology in Dogs, Leading the Way Towards Treating Human PDE6A-Retinitis Pigmentosa","volume":"28","author":"Occelli","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/humc.2018.188","article-title":"Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman Primates","volume":"30","author":"Tobias","year":"2019","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.035_bib88","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/hum.2022.222","article-title":"The Degree of Adeno-Associated Virus-Induced Retinal Inflammation Varies Based on Serotype and Route of Delivery: Intravitreal, Subretinal, or Suprachoroidal","volume":"34","author":"Wiley","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.06.035_bib89","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib90","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.omtm.2023.02.002","article-title":"Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B","volume":"28","author":"Ferla","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.06.035_bib91","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaophthalmol.2020.1032","article-title":"Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia","volume":"138","author":"Fischer","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib92","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamaophthalmol.2022.6254","article-title":"Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations","volume":"141","author":"Von Krusenstiern","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib93","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2022.06.006","article-title":"Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I\/II Gene Therapy Trial","volume":"129","author":"Aleman","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.06.035_bib94","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1167\/iovs.18-24708","article-title":"RDH12 mutations cause a severe retinal degeneration with relatively spared rod function","volume":"59","author":"Aleman","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib95","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ophtha.2016.10.022","article-title":"Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study","volume":"124","author":"Aleman","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.06.035_bib96","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1167\/iovs.15-17857","article-title":"Cobalamin C deficiency shows a rapidly progressing maculopathy with severe photoreceptor and ganglion cell loss","volume":"56","author":"Bonafede","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajo.2023.05.009","article-title":"First-in-Human Gene Therapy Trial of AAV8-hCARp.hCNGB3 in Adults and Children With CNGB3-associated Achromatopsia","volume":"253","author":"Michaelides","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib98","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000659","article-title":"Safety and Efficacy of Subretinal Readministration of a Viral Vector in Large Animals to Treat Congenital Blindness","volume":"2","author":"Amado","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.06.035_bib99","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2025.06.035_bib100","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/OPX.0b013e318264e85a","article-title":"The Berkeley Rudimentary Vision Test","volume":"89","author":"Bailey","year":"2012","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib101","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.06.035_bib102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10633-009-9204-7","article-title":"Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST)","volume":"119","author":"Klein","year":"2009","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib103","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1167\/iovs.19-27156","article-title":"Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis Due to CEP290 or NPHP5 Mutations: Predictions From Artificial Intelligence","volume":"60","author":"Sumaroka","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092928","article-title":"Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy","volume":"9","author":"Boye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.06.035_bib105","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1167\/iovs.17-21909","article-title":"Pupillary Light Reflexes in Severe Photoreceptor Blindness Isolate the Melanopic Component of Intrinsically Photosensitive Retinal Ganglion Cells","volume":"58","author":"Charng","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.visres.2020.01.006","article-title":"Transient pupillary light reflex in CEP290- or NPHP5-associated Leber congenital amaurosis: Latency as a potential outcome measure of cone function","volume":"168","author":"Krishnan","year":"2020","journal-title":"Vis. Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.65.12.27","article-title":"Multicenter Normative Data for Mesopic Microperimetry","volume":"65","author":"Pfau","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100907","article-title":"Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials","volume":"82","author":"Pfau","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2025.06.035_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910639","article-title":"Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy","volume":"25","author":"Cideciyan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib110","first-page":"49","article-title":"The Freiburg Visual Acuity test--automatic measurement of visual acuity","volume":"73","author":"Bach","year":"1996","journal-title":"Optom. Vis Sci."},{"key":"10.1016\/j.ymthe.2025.06.035_bib111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ceo.13022","article-title":"Novel mobility test to assess functional vision in patients with inherited retinal dystrophies","volume":"46","author":"Chung","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.06.035_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2019.09.2477","article-title":"PRO148 PSYCHOMETRIC EVALUATION OF A MODIFIED VISUAL FUNCTION QUESTIONNAIRE (MVFQ-25) USING DATA FROM A PHASE III OPEN-LABEL RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH INHERITED RETINAL DYSTROPHY CAUSED BY BIALLELIC RPE65 MUTATIONS","volume":"22","author":"Viriato","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.ymthe.2025.06.035_bib113","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041298","article-title":"Beyond the NEI-VFQ: Recent Experience in the Development and Utilization of Patient-Reported Outcomes for Inherited Retinal Diseases","volume":"13","author":"Durham","year":"2023","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:48Z","timestamp":1792788588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625004861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1525001625004861"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I\/II trial","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}